Quest Diagnostics Debt to Equity Ratio 2010-2024 | DGX

Current and historical debt to equity ratio values for Quest Diagnostics (DGX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Quest Diagnostics debt/equity for the three months ending September 30, 2024 was 0.83.
Quest Diagnostics Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $9.25B $6.84B 1.35
2024-06-30 $7.23B $6.66B 1.09
2024-03-31 $7.49B $6.47B 1.16
2023-12-31 $7.68B $6.34B 1.21
2023-09-30 $7.02B $6.46B 1.09
2023-06-30 $7.14B $6.29B 1.14
2023-03-31 $6.71B $6.09B 1.10
2022-12-31 $6.91B $5.93B 1.17
2022-09-30 $6.95B $6.27B 1.11
2022-06-30 $6.86B $6.45B 1.06
2022-03-31 $7.03B $6.42B 1.10
2021-12-31 $7.13B $6.48B 1.10
2021-09-30 $7.14B $6.43B 1.11
2021-06-30 $6.92B $5.94B 1.17
2021-03-31 $7.14B $6.79B 1.05
2020-12-31 $7.22B $6.81B 1.06
2020-09-30 $7.70B $6.45B 1.19
2020-06-30 $7.11B $5.88B 1.21
2020-03-31 $6.35B $5.70B 1.11
2019-12-31 $7.16B $5.69B 1.26
2019-09-30 $6.37B $5.65B 1.13
2019-06-30 $6.25B $5.51B 1.14
2019-03-31 $6.60B $5.34B 1.24
2018-12-31 $5.74B $5.27B 1.09
2018-09-30 $5.62B $5.37B 1.05
2018-06-30 $5.48B $5.26B 1.04
2018-03-31 $5.63B $5.07B 1.11
2017-12-31 $5.55B $4.96B 1.12
2017-09-30 $5.61B $4.83B 1.16
2017-06-30 $5.44B $4.73B 1.15
2017-03-31 $5.45B $4.66B 1.17
2016-12-31 $5.44B $4.66B 1.17
2016-09-30 $5.48B $4.69B 1.17
2016-06-30 $5.54B $4.57B 1.21
2016-03-31 $5.43B $4.67B 1.16
2015-12-31 $5.25B $4.71B 1.11
2015-09-30 $5.45B $4.62B 1.18
2015-06-30 $5.38B $4.34B 1.24
2015-03-31 $6.34B $4.27B 1.49
2014-12-31 $5.53B $4.33B 1.28
2014-09-30 $5.59B $4.21B 1.33
2014-06-30 $5.64B $4.12B 1.37
2014-03-31 $5.53B $4.02B 1.38
2013-12-31 $4.98B $3.97B 1.25
2013-09-30 $5.06B $3.87B 1.31
2013-06-30 $5.10B $3.94B 1.29
2013-03-31 $5.08B $4.23B 1.20
2012-12-31 $5.10B $4.19B 1.22
2012-09-30 $5.12B $4.20B 1.22
2012-06-30 $5.37B $4.02B 1.34
2012-03-31 $5.56B $3.90B 1.43
2011-12-31 $5.60B $3.72B 1.51
2011-09-30 $5.78B $3.55B 1.63
2011-06-30 $5.98B $3.45B 1.73
2011-03-31 $5.99B $3.24B 1.85
2010-12-31 $4.47B $4.05B 1.10
2010-09-30 $4.58B $3.88B 1.18
2010-06-30 $4.54B $3.95B 1.15
2010-03-31 $4.59B $3.93B 1.17
2009-12-31 $4.55B $4.01B 1.14
2009-09-30 $4.43B $3.94B 1.12
2009-06-30 $4.45B $3.77B 1.18
2009-03-31 $4.81B $3.53B 1.36
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.988B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00